Zobrazeno 1 - 10
of 2 794
pro vyhledávání: '"JAK Inhibitors"'
Publikováno v:
Journal of Asthma and Allergy, Vol Volume 17, Pp 1259-1263 (2024)
Xinyi Shao,* Xingyu Pan,* Yangmei Chen, Yan Zhu, Shuang Chen, Jin Chen Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, People’s Republic of China*These authors contributed equ
Externí odkaz:
https://doaj.org/article/222ecbbc202847708b2cd99ab8fc322e
Autor:
Yuki M.F. Andersen, MD, PhD, Johan Sieborg, MSc, Lea Nymand, MSc, Tiago Torres, MD, PhD, Andrea Chiricozzi, MD, Simon Francis Thomsen, MD, PhD, DMSc, Jacob P. Thyssen, MD, PhD, DMSc, Alexander Egeberg, MD, PhD, DMSc
Publikováno v:
JAAD International, Vol 17, Iss , Pp 61-66 (2024)
Background: Oral Janus kinase inhibitors (JAKis) have black-box warnings of infections, cancer risk, and cardiovascular and venous thromboembolic events. They may be used off-label for chronic hand eczema (CHE). Objectives: Assess the prevalence of r
Externí odkaz:
https://doaj.org/article/3ba95f7d0da343db9b828f7dff3c40bd
Autor:
Karoline Strobl, Jörg Klufa, Regina Jin, Lena Artner-Gent, Dana Krauß, Philipp Novoszel, Johanna Strobl, Georg Stary, Igor Vujic, Johannes Griss, Martin Holcmann, Matthias Farlik, Bernhard Homey, Maria Sibilia, Thomas Bauer
Publikováno v:
EMBO Molecular Medicine, Vol 16, Iss 12, Pp 3142-3168 (2024)
Abstract The hair follicle stem cell niche is an immune-privileged microenvironment, characterized by reduced antigen presentation, thus shielding against permanent immune-mediated tissue damage. In this study, we demonstrated the protective role of
Externí odkaz:
https://doaj.org/article/f4e87ecee1874448b2a1004628e97eb8
Autor:
Boulos Haraoui, Majed Khraishi, Denis Choquette, Isabelle Fortin, Cassandra D. Kinch, Corina Galos, Patrice Roy, David Gruben, Julie Vaillancourt, John S. Sampalis, Edward C. Keystone
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 6, Pp 1629-1648 (2024)
Abstract Introduction ORAL Surveillance, a post-authorisation safety study of patients with rheumatoid arthritis (RA) enriched for cardiovascular (CV) risk, demonstrated increased risk of major adverse CV events (MACE) and malignancies (excluding non
Externí odkaz:
https://doaj.org/article/214537ed140d4f4797dda101eed1469c
Publikováno v:
Patient Preference and Adherence, Vol Volume 18, Pp 2307-2310 (2024)
Yan Teng, Yi Tang, Yibin Fan, Xiaohua Tao,* Yang Ding* Center for Plastic & Reconstructive Surgery, Department of Dermatology, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital of Hangzhou Medical College, Hangzhou, Peop
Externí odkaz:
https://doaj.org/article/e8ad4bafd4d64b2fa0e0fdefe20322d9
Autor:
Daniel Isufi, BSc(Med), Mikkel Bak Jensen, MD, Nikolai Loft, MD, PhD, Lone Skov, MD, PhD, DMSc, Jesper Elberling, MD, PhD, Farzad Alinaghi, MD, PhD
Publikováno v:
JAAD International, Vol 18, Iss , Pp 106-116 (2025)
Janus kinase (JAK) inhibitors block pathways involved in inflammation and immune response, making JAK inhibitors useful in the treatment of various diseases. While the efficacy of these drugs has been proven in several studies, their safety profile n
Externí odkaz:
https://doaj.org/article/b7cfb694dc984328bc812dac7b138985
Publikováno v:
Cell Communication and Signaling, Vol 22, Iss 1, Pp 1-20 (2024)
Abstract Myelofibrosis (MF) is a complex myeloproliferative neoplasm characterized by abnormal hematopoietic stem cell proliferation and subsequent bone marrow (BM) fibrosis. First documented in the late 19th century, MF has since been extensively st
Externí odkaz:
https://doaj.org/article/b3fd08c1e5694a448164f5ef797abca5
Autor:
Matteini E, Diluvio L, Lambiase S, Cioni A, Gaeta Shumak R, Costanza G, Lanna C, Caldarola G, Bianchi L, Campione E
Publikováno v:
Clinical, Cosmetic and Investigational Dermatology, Vol Volume 17, Pp 2225-2230 (2024)
Enrico Matteini,1,* Laura Diluvio,1,* Sara Lambiase,1 Arnaldo Cioni,1 Ruslana Gaeta Shumak,1 Gaetana Costanza,2 Caterina Lanna,1 Giacomo Caldarola,3,4 Luca Bianchi,1 Elena Campione1 1Dermatology Unit, Department of Systems Medicine, Universit
Externí odkaz:
https://doaj.org/article/e26b93fd460c4f09a3cc330b3bf1347d
Autor:
Alexis Ogdie, Lars E. Kristensen, Enrique R. Soriano, Servet Akar, Yanhui Sun, David Gruben, Lara Fallon, Cassandra D. Kinch, Dafna D. Gladman
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 6, Pp 1649-1664 (2024)
Abstract Introduction Routine care studies of psoriatic arthritis (PsA) and ankylosing spondylitis (AS) demonstrated attenuated responses to tumor necrosis factor inhibitors in current/past versus never smokers. This post hoc analysis assessed tofaci
Externí odkaz:
https://doaj.org/article/e7e37982bed941ab871e32ad56487ec9
Autor:
Andrea Picchianti Diamanti, Maria Sofia Cattaruzza, Simonetta Salemi, Roberta Di Rosa, Giorgio Sesti, Chiara De Lorenzo, Gloria Maria Felice, Bruno Frediani, Caterina Baldi, Maria Sole Chimenti, Arianna D’Antonio, Gloria Crepaldi, Michele Maria Luchetti, Valentino Paci, Alen Zabotti, Ivan Giovannini, Marco Canzoni, Giandomenico Sebastiani, Chiara Scirocco, Carlo Perricone, Bruno Laganà, Annamaria Iagnocco
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 5, Pp 1347-1361 (2024)
Abstract Introduction Clinical remission is the main target in the management of patients with rheumatoid arthritis (RA). However, several authors found synovitis in patients with RA in clinical remission at ultrasonography (US). Upadacitinib is a se
Externí odkaz:
https://doaj.org/article/d17f65c67a4f4cf9999e97bded1dc1c1